Effect of 593C>T GPx1 SNP alone and in synergy with 47C>T SOD2 SNP on the outcome of critically ill patients  by Majolo, Fernanda et al.
Cytokine 71 (2015) 312–317Contents lists available at ScienceDirect
Cytokine
journal homepage: www.journals .e lsevier .com/cytokineEffect of 593C > T GPx1 SNP alone and in synergy with 47C > T SOD2 SNP
on the outcome of critically ill patientshttp://dx.doi.org/10.1016/j.cyto.2014.10.020
1043-4666/ 2014 Elsevier Ltd. All rights reserved.
⇑ Corresponding author at: Cell Culture Laboratory, Postgraduate program in
Biotechnology, Centro Universitário UNIVATES (UNIVATES), Brazil and Cellular and
Molecular Laboratory, Medicine School, Pontifícia Universidade Católica do Rio
Grande do Sul (PUCRS), Brazil.
E-mail address: fernandamajolo@hotmail.com (F. Majolo).Fernanda Majolo a,b,⇑, Francis Jackson de Oliveira Paludo c, Aline Ponzoni a, Pietra Graebin a,
Fernando Suparregui Dias d, Clarice Sampaio Alho a
aHuman and Molecular Genetic Laboratory, Biosciences School, Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Brazil
bCell Culture Laboratory, Postgraduate program in Biotechnology, Centro Universitário UNIVATES (UNIVATES), Brazil and Cellular and Molecular Laboratory, Medicine
School, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Brazil
cDepartment of Biochemistry, Institute of Basic Health Sciences (ICBS), Universidade Federal Do Rio Grande Do Sul (UFRGS), Brazil
d Intensive Care Unit of São Lucas Hospital, Pontifícia Universidade Católica Do Rio Grande Do Sul (PUCRS), Brazil
a r t i c l e i n f oArticle history:
Received 11 June 2014
Received in revised form 12 September
2014
Accepted 28 October 2014
Available online 11 December 2014
Keywords:
Critical illness
GPx1
Sepsis
Septic shock
SOD2a b s t r a c t
During critical illness and sepsis there is severe antioxidant depletion, and this scenario raises the critical
ill patient’s mortality risk. Glutathione peroxidase (GPx) is one of the ﬁrst endogenous antioxidant
defense enzymes, and it works cooperatively with superoxide dismutase (SOD) and catalase (CAT) to
detoxify free radicals from the cellular environment. Genetic studies are important to understand the
complexity of human oxidative stress and how the organism responds to an extreme situation such as
critically care conditions. Previous studies with a GPx1 single nucleotide polymorphism (593C > T SNP;
rs1050450; protein variant in GPx1: Pro198Leu) showed 593T carriers and 593TT homozygotes present
higher risk to develop different diseases. We assessed the relationship of the genotype distribution of
GPx1 SNP in critically ill patients with their conditions (organ dysfunction, sepsis, and septic shock)
and their outcome. We monitored 626 critically ill patients daily from the ICU (intensive care unit)
admission to their discharge from hospital, or death. Our study revealed a signiﬁcant association between
593TT GPx1 genotype and mortality; the mortality rate was higher in homozygous 593TT GPx1 (N = 94)
when compared with the group of subjects with genotypes 593CT or 593CC GPx1 (N = 532) (52% vs. 38%,
P = 0.009; OR = 1.79; 95% CI = 1.13–2.85). Evaluating the subgroup of 293 ICU patients with sepsis, a
pooled analysis including two genetic variants GPx1 and SOD2 (47C > T SNP, rs4880; protein variant in
MnSOD: Ala–9Val) showed a signiﬁcant difference in relation to progression to septic shock. The fre-
quency of septic shock among septic patients with 593T GPx1 and 47C SOD2 alleles (N = 122) was higher
when compared with septic patients carrying other settings of genotypes (N = 174) (78% vs. 66%;
P = 0.028; OR = 1.81; 95% CI = 1.03–3.18). Accepting the previously reported functional effects of these
two SNPs on GPx1 and SOD2 gene expressions and, consequently, on GPx1 and MnSOD enzyme activities,
we believe our results may be considered as an important contribution for the understanding of oxidative
imbalance during the critical ill.
 2014 Elsevier Ltd. All rights reserved.1. Introduction
Patients admitted to the Intensive Care Unit (ICU) are described
as presenting with a critical and complex pathological condition
resulting from severe physiological weakness [1]. Infections and
inﬂammatory processes prolong the length of stay of these patientsin the unit and increase their organ dysfunction and mortality rates
[2]. Critical illness is characterized by oxidative stress, which is a
major promoter of systemic inﬂammation and organ failure due
to excessive free radical production, depletion of antioxidant
defenses, or both [3]. In oxidative stress, the level of toxic reactive
oxygen intermediates overcome the endogenous antioxidant
defenses of the host and damage biologically relevant molecules,
such as DNA, RNA, proteins, carbohydrates, and unsaturated fatty
acids of the cell membranes [4–7]. Oxidative stress may not be
considered an epiphenomenon in the critically ill patient but part
of the underlying pathophysiologic events leading to mitochon-
drial dysfunction and systemic inﬂammatory response syndrome
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dysfunction syndrome (MODS) [8] and death. During critical
illness, the most severe cases of infection (SIRS, sepsis, or septic
shock) are associated with the most severe antioxidant depletion
[9–11], and this scenario raises the ICU patient’s mortality risk.
However, even without organ dysfunctions or severe infection
(sepsis or septic shock) some ICU patients can have a positive out-
come. It can be explained, at least in part, by the individual’s
genetic constitution, since some genes have polymorphic variants
that help the body recover from this critical condition. Otherwise,
some genetic variants may predispose the patient to a worse
outcome.
Paludo et al. (2013) showed a signiﬁcant higher frequency of
septic shock in septic ICU patients with the 47C allele of the man-
ganese superoxide dismutase gene (SOD2, locus 6q25) [12]. The
single nucleotide polymorphism (SNP) on SOD2 gene (47C > T;
rs4880; Ala–9Val signal peptide mutation on MnSOD) synthesizes
a manganese-dependent superoxide dismutase (MnSOD, EC
1.15.1.1) with different activities; the alanine version of MnSOD
(codiﬁed by the 47C allele) is predicted to lead to higher mitochon-
drial MnSOD activity than the valine (codiﬁed by the 47T allele)
isoform [13]. The higher 47C allele frequency in septic patients
with negative outcome found by Paludo et al. [12] could be
explained by effects of higher MnSOD activity on cellular stress
during sepsis. The human antioxidant endogenous defense system
consists of a variety of extracellular and intracellular antioxidants
that are able to protect cells and tissues from reactive oxygen spe-
cies (ROS) [7]. The balance of antioxidant enzymes activity such as
SOD, catalase, or glutathione peroxidase (GPx) is, therefore, crucial.
The defense mechanism against damage by ROS, SOD plus GPx or
catalase eliminates many damaging oxygen species; SOD catalyzes
the dismutation of superoxide anion (O2) into hydrogen peroxide
(H2O2) plus O2 [14]. However, the damage caused by H2O2 can be
removed by GPx1 which uses glutathione (GSH) as the reducing
agent, or by catalase; both glutathione peroxidases and catalase
convert H2O2 to O2 + H2O [15]. When intracellular antioxidants
such as SOD and GPx1 are not able to act perfectly in ICU patients
during critical condition, cellular/tissue damage may be higher and
the overall patient outcome may be worse.
Since 1957, GPx1 is known as an erythrocyte enzyme that
protects hemoglobin from oxidative injury [16]. It is part of the
enzymatic antioxidant defense preventing oxidative damage to
DNA, proteins and lipids by detoxifying hydrogen and lipid perox-
ides. GPx1 is expressed in almost all tissues, and also is abundant in
organs such as kidney and liver [17]. A SNP in the GPx1 gene
(593C > T; rs1050450; Pro198Leu protein mutation on the GPx1
enzyme) has the 593T allele and the 593TT genotype associated
with different diseases (Table 1). This SNP alters the conformationTable 1
Recent studies with 593C > T GPx1 polymorphism in different conditions.
Author Subjects’ origin N
Ratnasinghe et al. 2000 [34] European 315
Hansen et al. 2009 [26] European 1154
Jablonska 2009 [43] European 405
Kucukgergin et al. 2011 [32] Eurasian 293
Gurbuzier et al. 2012 [27] Eurasian 314
Zheikova et al. 2012 [31] Eurasian 381
Nahon et al. 2012 [35] European 200
Ramprasath et al. 2012 [29] Asian 824
Zheikova et al. 2012 [31] European 210
Zhao et al. 2012 [28] Asian 768
Johnson Phillips et al. 2013 [30] North American 585
N: Number of cases + controls.
S: Signiﬁcant.
Ns: Not signiﬁcant.of the GPx1 enzyme, changing its efﬁciency; the protein codiﬁed by
593T allele has lower enzyme activity when compared to GPx1
codiﬁed by 593C allele [18].
In this study, it was genotyped the 593C > T GPx1 SNP in 626
ICU patients and further analysis were conducted regarding
patient’s organ dysfunctions, sepsis, septic shock, and mortality
rates. It was also considered the previous 47C > T SOD2 SNP geno-
typing of these critically ill patients to evaluate their outcome.2. Materials and methods
2.1. Design, subjects, and approval
In this study, we included a total of 626 critically ill adult
patients from the general intensive care unit (ICU) of São Lucas
Hospital, Porto Alegre, RS, Brazil, admitted between March 1st,
2002 and November 31st, 2006. Part of these patients has been
described by Fallavena et al. [19] and Fraga et al. [20]. Patients
were not eligible if they were diagnosed with HIV-infection or a
known immunodeﬁciency, taking immunosuppressive drugs, preg-
nant or lactating. All subjects were from southern Brazil, which is
composed by a singular genetic background: the majority of
subjects are of European origin (Portuguese, Italians, Spanish, and
Germans ancestry), and there is a small number of individuals with
African traits contributing to their genetic pool [21]. We assumed
that the environmental exposure has a crucial inﬂuence, this being
the reason why healthy subjects were not used as a control group.
As a result, we performed comparison among ICU patients only.
The study has been approved by the Research Ethics Committee
of Pontiﬁcal Catholic University of Rio Grande do Sul and the
informed written consent or assent to participate in the research
was obtained from all subjects or patients’ surrogates (CAAE
18473713.6.0000.5336; Process # 330.285).2.2. Phenotyping
Patients admitted to the ICU were diagnosed with sepsis, severe
sepsis and septic shock according to the American College of Chest
Physicians/Society of Critical Care Consensus Conference deﬁnition
[22]. SIRS (systemic inﬂammatory response syndrome) was deﬁned
by the presence of at least two of the following symptoms: fever or
hypothermia (core temperature > 38 C or b36 C); tachycardia
(>90 beats/min); tachypnea or hyperventilation (breaths/min > 20
or PaCO2b32 mmHg); leukocytosis (>12.000 mm3) or leucopenia
(b4.000 mm3). Sepsis was deﬁned as SIRS secondary to infection,
severe sepsis were sepsis complicated by organ dysfunction and,
septic shock if refractory arterial hypotension to ﬂuid replacement,Risk to Association with 593T GPx1 allele
Lung cancer S
Colorectal cancer Ns
More selenium in plasma S
Prostate cancer S
Tonsillitis; tonsillar hypertrophy Ns
Bladder cancer S
Hepatitis C with cirrhosis Ns
Diabetic cardiovascular disease S
Coronary artery disease S
Glioma S
Depression S
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APACHE-II (Acute Physiology And Chronic Health Evaluation II)
score [23] obtained on ICU admission day. Organ dysfunction eval-
uation was performed according to SOFA (Sequential Organ Failure
Assessment) [24] (Vincent et al. 1998) score obtained on ICU admis-
sion day (SOFA-1), on a daily basis during the ﬁrst week of ICU
admission (SOFA-2–SOFA-7) and on days 15 (SOFA-15) and 29
(SOFA-29) for patients that stayed in the ICU. Temporal variation
comprised length of stay (LOS) in ICU and hospital stay. Mortality
was measured in days until death in total hospital stay: clinical
endpoints of the study were discharge from the hospital (consid-
ered survivors), or death (considered non-survivors). For those
patients with multiple ICU admission during the study period, only
data from the ﬁrst entrance were considered. All clinical data were
collected and veriﬁed by ICU physicians with control ensure.
2.3. Genotyping
Genomic DNA was extracted from leucocytes by a standard
method [25]. The genotyping protocol for the determination of
593C > T GPx1 SNP was as follows: Polymerase Chain Reaction
(PCR) was performed at a total volume of 25 lL with about 10–
100 ng of genomic DNA, 2.5 lL Taq DNA Polymerase in Taq Buffer
(Life Technologies – Brazil Ltda. INVITROGEN Inv. São Paulo, SP,
Brazil), ﬁnal concentration of each dNTP 0.2 mM, and 2 mMMgCl2.
The segment of the GPx1 gene was ampliﬁed using primers sense
50-TGT GCC CCT ACG CAG GT-30, and anti-sense 50-CCA AAT GAC
AAT GAC ACA GG-30 (Life Technologies Ltda, Brazil. INVITROGEN
Inv. São Paulo, SP, Brazil). PCR was performed on Veriti thermocy-
cler from Applied Biosystems as follows: initial denaturation at
95 C for 5 min, followed by 35 cycles at 95 C for 40 s, 59 C for
1 min, and 72 C for 1 min and 30 s. The ﬁnal extension step was
prolonged to 10 min. The 338 bp ampliﬁcation product was quan-
tiﬁed (10–50 ng/ll) by Low Mass (Invitogen-Life Technologies, São
Paulo, Brazil) in 1% agarose gel. PCR products were directly
sequenced using the same primer sequences in the ABI 3730 XL
DNA Sequencer according to the manufacturer’s manual. Genotyp-
ing was performed by interpretation of chromatogram peaks by
sequencing FinchTV software version 1.4.0. We also performed a
second independent PCR restriction fragment length-polymor-
phism analysis in order to conﬁrm some genotypes; the 338 bp
PCR ampliﬁed product was cleaved in appropriated buffer with
100U of Apa I (GibcoBRL-Life Technologies™, Rockville, MD,
USA) at a total volume of 15 lL at 37 C for 8 h. We used a quality
control system to ensure genotyping accuracy: sequencing veriﬁ-
cation of the DNA ampliﬁed fragment, black controls, and
duplicates.
2.4. Statistical analysis
Statistical calculations were performed using the statistical
package BioEstat 5.3 (http://www.mamiraua.org.br/pt-br/). Unless
otherwise stated, continuous variable results are expressed as a
mean and standard deviation (SD), and categorical variables as fre-
quencies and percentage. Means were compared using one-way
analysis of variance, and non-normally distributed variables were
analyzed as non-parametric using Mann–Whitney test. For the cat-
egorical data we used Pearson chi-square test, also used to test for
Hardy–Weinberg equilibrium. To evaluate the inﬂuence of individ-
ual genotype on the patient outcome, excluding other risk factors
that could inﬂuence the mortality, we used multiple regression
analysis incorporating 593C > T genotypes and other clinical pre-
dictors. All reported P values are two-tailed and considered statis-
tically signiﬁcant when 0.05 or less. To explore 593C > T GPx1 and
47C > T SOD2 SNP data together, we assumed an independent seg-
regation since GPx1 gene is in chromosome 3 (3p21.3) and SOD2gene is in chromosome 6 (6q25). Using a sample of subjects with
DNA proﬁle to both SOD2 and GPx1 SNPs (N = 446), we clustered
the patients with simultaneously 593T GPx1 and 47C SOD2 alleles
(N = 198; double genotypes 593TT/47CC; 593TT/47CT; 593CT/
47CC; 593CT/47CT) versus the patients with other genotypes set-
ting (N = 248; double genotypes 593TT/47TT; 593CT/47TT;
593CC/47TT; 593CC/47CT; 593CC/47CC). We tested other clusters
but none of them was informative to detect differences related to
genetic variable.
3. Results
We obtained data of the ﬁrst day to a maximum of 224 days
from 626 patients admitted to the ICU. We evaluated the demo-
graphic, clinical and genetic proﬁle of 626 critically ill patients
clustered according sepsis (74%; 463/626) versus no-sepsis (26%;
163/626), septic shock (52%; 327/626) versus no-septic shock
(48%; 299/626), and mortality (40%; 250/626) versus no-mortality
(60%; 376/626). We observed no differences in sex, age, or length of
stay in ICU. SOFA and APACHE-II scores were signiﬁcant higher
among patients with sepsis, septic shock, and mortality (P < 0.05;
data no shown). The general genotypic and allelic frequencies in
ICU sample (n = 626) did not differ from the values expected by
the Hardy–Weinberg model (P = 0.654); the genotypic frequencies
were: 593CC = 0.41, 593CT = 0.44, and 593TT = 0.15. We did not
ﬁnd signiﬁcant association among the three genotypes comparing
patients according sepsis versus no-sepsis (P = 0.514) or septic
shock versus no-septic shock (P = 0.750) groups. However, when
they were clustered in mortality versus no-mortality groups the
patients showed signiﬁcant difference by CC, CT, and TT genotypes
(P = 0.0397). We tested dominant, recessive, and co-dominant
models for 593C and 593T alleles and observed that the 593C allele
had a dominant-like effect in mortality rate. Based on the informa-
tion that the 593C > T SNP alters the conformation of the GPx1
enzyme, changing its efﬁciency, and the protein codiﬁed by 593C
allele has higher enzyme activity when compared to GPx1 codiﬁed
by 593T allele [18], we assumed the dominant model to 593C allele
to perform our subsequent analysis.
Table 2 describes patient proﬁle grouped according to 593C > T
GPx1 SNP: patients with 593TT genotype (15%; 94/626) and with
593CT + 593CC genotypes (85%; 532/626). Through the analysis
of different variables (organ dysfunction, sepsis, and septic shock)
among all critically ill patients no signiﬁcant difference between
the two genotype groups were observed, except in relation to the
mortality rate. The rate of ICU mortality was signiﬁcantly higher
in the group of individuals with 593TT genotype than in the group
of individuals with 593CT or 593CC genotypes (52% vs. 38%,
P = 0.009; OR = 1.79; 95% CI = 1.13–2.85) (Table 2). Analyzing the
rates of mortality in the hospital (ICU period plus period in the hos-
pital after ICU discharge), the mortality rate remained signiﬁcantly
higher in the group of individuals with 593TT genotype than in the
group with individuals with 593CT or 593CC genotypes (61% vs.
49%, P = 0.037). When analyzing the different variables only among
septic patients (N = 463) or only among patients with septic shock
(N = 327) we observed no signiﬁcant difference between the two
genotype groups. In order to test whether it would be acceptable
or it would just be likely causality of this genetic study, we per-
formed the multiple regression test as an adjusted analysis, incor-
porating genotypes, sex, age, length of stay in ICU, and APACHE-II
scores to exclude other risk factors that could inﬂuence the out-
come. The analysis showed that only APACHE-II (t = 6.9850;
P < 0.001) was signiﬁcantly associated with mortality, but the
593TT genotype showed a trend towards association (t = 1.6318;
P = 0.1052).
Using a total sample of 446 ICU subjects with DNA proﬁle to
both SOD2 and GPx1 genes, we conducted an analysis, the same
Table 2
Critically ill patients’ clinical and demographic data according to the 593C > T GPx1 SNP genotype groups.
Variable ICU patients 593TT 593CT + CC P value Test
Frequency (N (%)) 626 (100.0) 94 (15.01) 532 (84.98) 0.654 HW
Female (N (%)) 300 (47.92) 42 (44.68) 258 (48.49) 0.495 CS
Age (mean (SD)) 54.76 (20.03) 55.22 (16.90) 54.68 (20.55) 0.923 MW
SOFA-1 (median (min–max)) 6.56 (1–18) 6.85 (1–17) 6.52 (1–18) 0.104 MW
SOFA-2 (median (min–max)) 6.51 (1–18) 6.59 (1–18) 6.50 (1–17) 0.882 MW
SOFA-3 (median (min–max)) 6.31 (1–18) 6.78 (1–18) 6.24 (1–18) 0.428 MW
SOFA-4 (median (min–max)) 6.20 (1–22) 6.58 (1–18) 6.14 (1–22) 0.512 MW
SOFA-5 (median (min–max)) 6.11 (1–20) 6.36 (1–20) 6.07 (1–19) 0.654 MW
SOFA-6 (median (min–max)) 6.07 (1–21) 6.07 (1–21) 6.07 (1–20) 0.748 MW
SOFA-7 (median (min–max)) 5.87 (1–24) 6.03 (1–18) 5.84 (1–24) 0.521 MW
SOFA-15 (median (min–max)) 5.95 (1–19) 6.85 (2–15) 5.82 (1–19) 0.656 MW
SOFA-29 (median (min–max)) 6.07 (1–14) 4.83 (3–10) 6.30 (1–14) 0.641 MW
APACHE-II score (mean (SD)) 19.03 (7.67) 19.56 (7.24) 18.94 (7.44) 0.276 MW
Sepsis (N (%)) 463 (73.96) 65 (69.14) 398 (74.81) 0.249 CS
Septic shock (N (%)) 327 (52.23) 50 (53.19) 277 (52.06) 0.841 CS
ICU LOS (median (min–max)) 17.78 (1–125) 18.64 (1–91) 17.63 (1–125) 0.350 MW
ICU + H LOS (median (min–max)) 37.29 (1–242) 33.91 (1–135) 37.90 (1–242) 0.743 MW
Mortality in ICU (N (%)) 250 (40.32) 49 (52.13) 201 (38.22) 0.009 CS
593TT = Homozygotes.
593CT + CC = Heterozygotes.
593CC = Homozygotes.
APACHE-II = Acute physiology and chronic health evaluation II.
ICU = Intensive care unit.
ICU + H = ICU plus hospital.
LOS = Length of stay.
N = Number.
SD = Standard deviation.
HW = Pearson chi-square test for Hardy–Weinberg equilibrium.
MW =Mann–Whitney U-test.
HW: Hardy–Weinberg.
CS: Chi-Square.
F. Majolo et al. / Cytokine 71 (2015) 312–317 315previous, including the two genotyping. We considered the
patients with 593T GPx1 and 47C SOD2 alleles (N = 198) versus
the patients with other genotypes setting (N = 248). The result
showed that it was not possible to detect a statistically signiﬁcant
difference between the two groups of critically ill patients in any of
the variables (sex, age, SOFA and APACHE-II scores, sepsis, septic
shock, or mortality). To explore all data, we performed more tests
with different approaches using diverse double genotype combina-
tion sets, but any important result has been found. When studying
the subgroup of septic subjects with double genotype DNA proﬁle
of both SOD2 and GPx1 genes (N = 296), we observed no differences
in the mortality rates in sex, age, or SOFA and APACHE-II scores;
however there was a signiﬁcant higher frequency of septic shock
in septic patients with 593T GPx1 and 47C SOD2 alleles (N = 122)
when compared to septic patients with other settings of genotypes
(N = 174) (78% vs. 66%; P = 0.028; OR = 1.81; 95% CI = 1.03–3.18).
This combined analyses conﬁrmed the association found by Paludo
et al. and also demonstrated an important synergistic relationship
between these two oxidative stress-related genes on the pheno-
type. This synergy between GPX1 and SOD2 gene is recognized,
but here we are demonstrating a synergy between 593C > T GPX1
and 47C > T SOD2 SNP acting on septic patients. We believe this
last result demonstrates a simultaneous effect of GPx1 and SOD2
gene variation inheritance on the outcome from sepsis.4. Discussion
Genetic studies are important to understand the complexity of
human oxidative stress, and how the organism responds to an
extreme situation such as critically care conditions. Glutathione
peroxidase (GPx) is one of the ﬁrst endogenous antioxidant defense
enzymes, and it works cooperatively to detoxify free radicals from
the cellular environment. Previous studies with this GPx1 SNP
(593C > T; rs1050450; Pro198Leu) showed that 593T carriers hadhigher risk to colorectal cancer [26], tonsillitis [27], glioma [28],
diabetic and cardiovascular disease [29] and depression [30]. Other
studies noticed that patients with 593TT GPx1 genotype had higher
rates of coronary artery disease [31], prostate cancer [32], bladder
cancer [33], lung cancer [34], and hepatitis C with cirrhosis [35]
when compared to 593CC GPx1 homozygotes. Our study revealed
a new signiﬁcant association of 593TT GPx1 genotype in critically
ill subjects with adverse outcome (mortality) when compared to
593CT + 593CC GPx1 subjects. It seems that the 593TT GPx1 patient
group was more susceptible during the critical state, evolving to
worse conditions of health and presenting a higher mortality rate.
However it is not so simple to explain the real causes of this rela-
tion because complex conditions in ICU patients are caused by
many physiological, biochemical, and other intrinsic (genetic) fac-
tors, and each factor alone has somewhat of an effect. The fragility
of a critically ill patient to sepsis/septic shock or to mortality in an
ICU is deﬁnitively not triggered by a single gene or factor. Instead
genes and multiple factors with small discrete effects are accumu-
lated with comorbidities increasing the risk to sepsis/septic shock
or to mortality. In this study it was important to observe that
APACHE-II score was stronger (P < 0.001) than GPx1 genotype
(P = 0.105) to predict mortality in a multivariable analysis. But
there was no signiﬁcant difference in APACHE-II scores between
593TT GPx1 patient group (with highest mortality rate) and
593CT + 593CC GPx1 patient group (with lowest mortality rate)
(P = 0.276). To search for candidate genetic markers to understand
a complex condition is a hard task since many genes interfere in a
net of intrinsic and extrinsic factors. It may be a challenge to detect
the single effect of each gene or each gene variation in this net.
Even though we were able to detect a striking association of a sin-
gle variant in the GPx1 gene since it was strong enough to appear as
a statistically signiﬁcant factor in the ICU patients’ outcome. Based
on our results, we believe the 593TT GPx1 genotype could be asso-
ciated, even if not directly, with a higher propensity of unbalanced
cell oxidative control, thus leading us to suggest the 593C > T GPx1
316 F. Majolo et al. / Cytokine 71 (2015) 312–317SNP, in its genomic context, as a candidate marker to help under-
stand the differential susceptibility to oxidative imbalance of the
critically ill patient.
The human’s antioxidant endogenous defense system consists
of a variety of extracellular and intracellular antioxidants that are
able to protect tissues from reactive oxygen species (ROS) and
reactive nitrogen species (RNS) induced injury [7]. SOD, catalase
and GPx enzymes need to be well coordinate expression and activ-
ities in the whole scenario. These antioxidants require trace ele-
ments, such as copper, manganese, zinc, iron, and selenium are
for their full activity [36]. Selenium, for example, is an essential
component of the intracellular antioxidant system as a structural
component of the active center of glutathione peroxidase enzymes.
Selenium enzymes play a major role in protecting cells against per-
oxidation, especially lipid peroxidation. Furthermore, selenium
seems to play a direct role in the regulation of inﬂammatory pro-
cesses and its deﬁciency is directly correlated to the severity of
the disease and the incidence of mortality [37]. Low levels of sele-
nium or other endogenous vitamins and trace elements during the
critical illness are also observed due to an escape to the interstitial
compartment by capillary leakage, hemodilution, previous insufﬁ-
cient intake, and continuous renal replacement therapies [38]. This
loss could explain why intracellular antioxidants such as GPx1 and
SOD enzymes were not able to act perfectly in ICU patients, given
that the patient is in critical condition and has loss of elements and
ions, even if the ICU patient does not present sepsis. Based on our
results we were not able to conclude if 593C > T GPx1 or 47C > T
SOD2 variants confer more or less susceptibility to ﬁx or decrease
the levels of elements and ions, we may only infer if they are inﬂu-
encing the patients’ outcome.
During critical illness the most severe cases of infection, like
sepsis, are associated to the most severe antioxidant depletion
[9–11], and this scenario raises the ICU patient’s mortality risk.
As reported previously, both 593T and 47C variants change the lev-
els and activities of GPx1 and SOD2 enzymes, respectively. GPx1
enzyme codiﬁed by 593T GPx1 allele has lower enzyme activity
than the GPx1 codiﬁed by 593C GPx1 allele [18]; and the alanine
version of MnSOD (codiﬁed by 47C SOD2 allele) is predicted to lead
to higher mitochondrial MnSOD activity than the valine (codiﬁed
by 47T SOD2 allele) isoform [13]. Thus, these genetic variants could
lead the patient to a worse outcome, since intracellular antioxi-
dants MnSOD and GPx1 are not able to act perfectly in ICU patients
during critical condition and cellular/tissue damage may be
higher.
Given that the ultimate levels of ROS depend on both dismuta-
tion of superoxide anion (O2) into hydrogen peroxide (H2O2) by
MnSOD and detoxiﬁcation of H2O2 by GPx1, and that 593C > T
GPx1 and 47C > T SOD2 SNPs inﬂuence the detoxiﬁcation pathway
of ROS, it is plausible hypothesize the combination of these two
genepolymorphisms has a deeper effect on disease risk than a single
gene polymorphism [33]. Cox et al. [39] exemplify this in a study in
that indicates no association between breast cancer and the two
gene polymorphisms when examined independently. However,
individuals carrying both 593TT GPx1 and 47CC SOD2 genotypes
had an increased risk of breast cancerwhen compared to individuals
carrying both 593CC GPx1 and 47TT SOD2 genotypes. In another
study, Ichimura et al. [40] found that the combination of both
593TT GPx1 and 47CC SOD2 genotypes conferred a highest risk for
bladder cancer with an odds ratio of 2.69 (95% CI = 1.25–5.80;
P = 0.011). Using the same methodology, Sutton et al. [41] showed
in a prospective cohort study alcoholic cirrhotic patients with the
high activity MnSOD version (47C SOD2 allele) and the low activity
GPx1 enzyme (593T GPx1 allele) presented a higher incidence of
hepacellular carcinoma in cirrhosis during follow-up. The authors
suggested that these genotypic associations could be explained by
an increase of mitochondrial superoxide production by the highdismutation rate of 47T SOD2 variant and slow detoxiﬁcation of
hydrogen peroxide by the low activity of 593T GPx1 variant
[41,42]. All of these results suggest that these genetic variants
may have a synergistic effect on the increase of disease risk.
The combined contribution of multiple genes and environmen-
tal factors affect the onset, the evolution and the outcome of com-
plex diseases. Each gene, or gene variation, contributes with its
particular small and cumulative effect to the ﬁnal phenotype. In
a previous study Paludo et al. [12] detected an important contribu-
tion of the 47C allele of 47C > T SOD2 SNP on septic shock outcome
in ICU septic patients. In their study with 356 septic ICU patients,
there was a signiﬁcant higher frequency of septic shock in septic
subjects with the 47C allele of the SOD2 gene. They compared
the 47C allele carriers (47CC + 47CT genotypes; N = 252) with
47TT homozygotes (N = 104) and noticed a signiﬁcant association
between 47C allele carriers and septic shock in septic patients
(78% vs. 66%; P = 0.025; OR = 1.78; 95% CI = 1.04–3.03). The authors
suggested the higher 47C allele frequency in septic patients with
negative outcome could be explained by effects of higher activity
of MnSOD on cellular stress during sepsis. In a combined analyses
with both GPx1 and SOD2 genetic variants, despite of other vari-
ables, we identiﬁed a signiﬁcant higher frequency of septic shock
in a group of septic patients with both 593T GPx1 and 47C SOD2
alleles when compared to septic patients with other settings of
genotypes (78% vs. 66%; P = 0.028; OR = 1.81; 95% CI = 1.03–3.18).
Combined analyses can be difﬁcult to process because they need
a very large sample size for comparisons and statistic power. How-
ever, even with the smaller sample size in this last analysis
(N = 296), this result could be important to consider future
advanced approaches. Combined genetic analysis with more than
one SNP are especially interesting because it may demonstrate that
the synergic effect of two gene variations could be stronger than
single GPx1 or SOD2 SNP effects. In association studies, the com-
bined detection of independently segregated SNPs may provide a
deeper insight about simultaneously interaction of genes, and
how it affects the phenotype.
Another important aspect to consider is epigenetic, that is the
study of how molecules binging on DNA can produce signiﬁcantly
different phenotypes as a result of differing biochemical changes
that alter gene availability for protein production [44,45]. It can
explain why exists differences in patient and population in
susceptibility to illness, clinical course, and outcomes. Epigenetic
mechanisms, as DNA methylation, can result in increased or
decreased gene products. When gene expression is altered, the
potential for signiﬁcant phenotypical alterations to pathology,
disease progression, and short- and long-term outcomes exists.
Epigenetic regulation, in which gene expression is altered and
may signiﬁcantly impact critical illness outcomes, can occur
through direct methylation of DNA cytosine bases resulting in
downregulation of genes. Alternatively, demethylation might
upregulate expression of genes.
Both 593C > T GPX1 and 47C > T SOD2 SNPs has cytosine
exchange, that may be affected by mutilation. The prior epigenetic
changes of somatic cells could thus have a direct effect on an
individual’s ability to respond to sepsis in the future [46].
Here, we worked with over 600 patients in critical conditions;
we performed comparisons among ICU patients, and we did not
use healthy subjects as control group to exclude the crucial
inﬂuence of environmental exposure. Our study was able to
demonstrate the effect of 593C > T GPx1 and 47C > T SOD2 SNPs
on ICU patient outcome with statistical signiﬁcance. Accepting
the previously reported functional effects of these two SNPs on
GPx1 and SOD2 gene expressions and, consequently, on GPx1
and MnSOD enzyme activities, we believe our results may be
considered as an important contribution for the understanding of
oxidative imbalance during the critical ill.
F. Majolo et al. / Cytokine 71 (2015) 312–317 3175. Conclusion
The present study provides statistically founded evidence that
the 593C > T GPx1 SNP alone or in synergic effect with 47C > T
SOD2 SNP is associated with the outcome of critically ill patients.
The GPx1 polymorphism and its genomic context can provide
insights for understanding the oxidative stress since its genetic
variants have been previously reported to result in changes in
enzyme levels and activities.Acknowledgments
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